Trexquant Investment LP Invests $6.10 Million in Mettler-Toledo International Inc. (NYSE:MTD)

Trexquant Investment LP bought a new position in shares of Mettler-Toledo International Inc. (NYSE:MTD) in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 4,985 shares of the medical instruments supplier’s stock, valued at approximately $6,100,000.

A number of other hedge funds have also added to or reduced their stakes in MTD. JPMorgan Chase & Co. grew its holdings in shares of Mettler-Toledo International by 14.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 221,799 shares of the medical instruments supplier’s stock valued at $332,634,000 after acquiring an additional 28,478 shares in the last quarter. M&T Bank Corp boosted its position in Mettler-Toledo International by 14.3% during the third quarter. M&T Bank Corp now owns 4,926 shares of the medical instruments supplier’s stock valued at $7,387,000 after purchasing an additional 615 shares during the last quarter. Allworth Financial LP boosted its position in Mettler-Toledo International by 367.4% during the fourth quarter. Allworth Financial LP now owns 215 shares of the medical instruments supplier’s stock valued at $285,000 after purchasing an additional 169 shares during the last quarter. Nordea Investment Management AB grew its stake in Mettler-Toledo International by 29.8% in the fourth quarter. Nordea Investment Management AB now owns 105,823 shares of the medical instruments supplier’s stock valued at $129,919,000 after purchasing an additional 24,285 shares in the last quarter. Finally, Robeco Institutional Asset Management B.V. increased its position in shares of Mettler-Toledo International by 18.0% during the 4th quarter. Robeco Institutional Asset Management B.V. now owns 34,370 shares of the medical instruments supplier’s stock worth $42,058,000 after purchasing an additional 5,234 shares during the last quarter. Institutional investors own 95.07% of the company’s stock.

Mettler-Toledo International Trading Down 6.7 %

Shares of NYSE MTD opened at $1,021.97 on Friday. The business’s 50 day moving average is $1,264.13 and its 200-day moving average is $1,295.07. The firm has a market cap of $21.30 billion, a P/E ratio of 25.22, a price-to-earnings-growth ratio of 3.30 and a beta of 1.15. Mettler-Toledo International Inc. has a 1-year low of $1,000.72 and a 1-year high of $1,546.93.

Mettler-Toledo International (NYSE:MTD) last posted its earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share for the quarter, topping analysts’ consensus estimates of $11.76 by $0.65. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.29%. Analysts forecast that Mettler-Toledo International Inc. will post 42.71 EPS for the current year.

Insider Buying and Selling at Mettler-Toledo International

In related news, insider Christian Magloth sold 790 shares of the business’s stock in a transaction that occurred on Monday, February 24th. The stock was sold at an average price of $1,313.69, for a total value of $1,037,815.10. Following the completion of the sale, the insider now directly owns 734 shares in the company, valued at approximately $964,248.46. The trade was a 51.84 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Gerry Keller sold 600 shares of the firm’s stock in a transaction on Monday, February 10th. The stock was sold at an average price of $1,351.34, for a total value of $810,804.00. Following the transaction, the insider now owns 6 shares in the company, valued at approximately $8,108.04. This trade represents a 99.01 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.94% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on MTD shares. Citigroup decreased their target price on shares of Mettler-Toledo International from $1,450.00 to $1,400.00 and set a “neutral” rating for the company in a research note on Tuesday, March 4th. Robert W. Baird boosted their price objective on shares of Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the stock a “neutral” rating in a research note on Monday, February 10th. Evercore ISI raised their target price on shares of Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the company an “outperform” rating in a research note on Monday, February 10th. Wolfe Research assumed coverage on Mettler-Toledo International in a research report on Friday, December 13th. They set a “peer perform” rating on the stock. Finally, Wells Fargo & Company raised their price objective on Mettler-Toledo International from $1,350.00 to $1,400.00 and gave the company an “equal weight” rating in a research report on Monday, February 10th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat.com, Mettler-Toledo International currently has an average rating of “Hold” and a consensus target price of $1,380.50.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.